FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 356:1823-1834 May 3, 2007 Number 18 Next

Murat Sezer, M.D., Hüseyin Oflaz, M.D., Taner Gören, M.D., rem Okçular, M.D., Berrin Umman, M.D., Yilmaz Nianci, M.D., Ahmet Kaya Bilge, M.D., Yasemin anli, M.D., Mehmet Meriç, M.D., and Sabahattin Umman, M.D.

	Full Text PDF PDA Full Text PowerPoint Slide Set Editorial by Piek, J. J. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

ABSTRACT

Background Microvascular perfusion is often impaired after primary percutaneous coronary intervention (PCI). We proposed that in situ thrombosis might contribute to poor myocardial perfusion in this setting. To test this hypothesis, we evaluated the effect of low-dose intracoronary streptokinase administered immediately after primary PCI.

Methods Forty-one patients undergoing primary PCI were randomly assigned to receive intracoronary streptokinase (250 kU) or no additional therapy. Two days later, cardiac catheterization was repeated, and coronary hemodynamic end points were measured with the use of a guidewire tipped with pressure and temperature sensors. In patients with anterior myocardial infarction, the deceleration time of coronary diastolic flow was measured with transthoracic echocardiography. At 6 months, angiography, echocardiography, and technetium-99m single-photon-emission computed tomography were performed.

Results Two days after PCI, all measures of microvascular function (means ±SD) were significantly better in the streptokinase group than in the control group, including coronary flow reserve (2.01±0.57 vs. 1.39±0.31), the index of microvascular resistance (16.29±5.06 U vs. 32.49±11.04 U), the collateral-flow index (0.08±0.05 vs. 0.17±0.07), mean coronary wedge pressure (10.81±5.46 mm Hg vs. 17.20±7.93 mm Hg), systolic coronary wedge pressure (18.24±6.07 mm Hg vs. 33.80±11.00 mm Hg), and diastolic deceleration time (828±258 msec vs. 360±292 msec). The administration of intracoronary streptokinase was also associated with a significantly lower corrected Thrombolysis in Myocardial Infarction frame count (the number of cine frames required for dye to travel from the ostium of a coronary artery to a standardized distal coronary landmark) at 2 days. At 6 months, however, there was no evidence of a difference between the two study groups in left ventricular size or function.

Conclusions In our pilot trial, the administration of low-dose intracoronary streptokinase immediately after primary PCI improved myocardial reperfusion but not long-term left ventricular size or function. These findings require clarification in a larger trial. (ClinicalTrials.gov number, NCT00302419 [ClinicalTrials.gov] .)

Source Information

From the Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Address reprint requests to Dr. Sezer at Istanbul University, Istanbul Faculty of Medicine, Department of Cardiology, Istanbul, Turkey, or at sezerm{at}istanbul.edu.tr.

Full Text of this Article

This article has been cited by other articles:

• Prasad, A., Stone, G. W., Holmes, D. R., Gersh, B. (2009). Reperfusion Injury, Microvascular Dysfunction, and Cardioprotection: The "Dark Side" of Reperfusion. Circulation 120: 2105-2112 [Full Text]  
• Sezer, M., Cimen, A., Aslanger, E., Elitok, A., Umman, B., Bugra, Z., Yormaz, E., Turkmen, C., Adalet, I.s., Nisanci, Y., Umman, S. (2009). Effect of intracoronary streptokinase administered immediately after primary percutaneous coronary intervention on long-term left ventricular infarct size, volumes, and function.. J Am Coll Cardiol 54: 1065-1071 [Abstract] [Full Text]  
• Kitabata, H., Imanishi, T., Kubo, T., Takarada, S., Kashiwagi, M., Matsumoto, H., Tsujioka, H., Ikejima, H., Arita, Y., Okochi, K., Kuroi, A., Ueno, S., Kataiwa, H., Tanimoto, T., Yamano, T., Hirata, K., Nakamura, N., Tanaka, A., Mizukoshi, M., Akasaka, T. (2009). Coronary Microvascular Resistance Index Immediately After Primary Percutaneous Coronary Intervention as a Predictor of the Transmural Extent of Infarction in Patients With ST-Segment Elevation Anterior Acute Myocardial Infarction.. J Am Coll Cardiol Img 2: 263-272 [Abstract] [Full Text]  
• Gibson, C. M., Zorkun, C., Kunadian, V. (2008). Intracoronary Administration of Abciximab in ST-Elevation Myocardial Infarction. Circulation 118: 6-8 [Full Text]  
• Thiele, H., Schindler, K., Friedenberger, J., Eitel, I., Furnau, G., Grebe, E., Erbs, S., Linke, A., Mobius-Winkler, S., Kivelitz, D., Schuler, G. (2008). Intracoronary Compared With Intravenous Bolus Abciximab Application in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: The Randomized Leipzig Immediate Percutaneous Coronary Intervention Abciximab IV Versus IC in ST-Elevation Myocardial Infarction Trial. Circulation 118: 49-57 [Abstract] [Full Text]  
• Dixon, S. R., Grines, C. L., O'Neill, W. W. (2008). The year in interventional cardiology.. J Am Coll Cardiol 51: 2355-2369 [Full Text]  
• Jaffe, R., Charron, T., Puley, G., Dick, A., Strauss, B. H. (2008). Microvascular Obstruction and the No-Reflow Phenomenon After Percutaneous Coronary Intervention. Circulation 117: 3152-3156 [Full Text]  
• Fearon, W. F., Shah, M., Ng, M., Brinton, T., Wilson, A., Tremmel, J. A., Schnittger, I., Lee, D. P., Vagelos, R. H., Fitzgerald, P. J., Yock, P. G., Yeung, A. C. (2008). Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction.. J Am Coll Cardiol 51: 560-565 [Abstract] [Full Text]  
• Lindsay, A. (2007). JournalScan. Heart 93: 1159-1160 [Full Text]  
• Piek, J. J. (2007). Beyond Epicardial Reperfusion. NEJM 356: 1880-1882 [Full Text]  
• (2007). Streptokinase Improves Microvascular Perfusion After Primary PCI. Journal Watch Cardiology 2007: 1-1 [Full Text]